Original Equipment Manufacturers (OEMs) are often placed in challenging situations when designing and delivering specialist equipment for pharmaceutical clients. Enzyme Indicators serve to complement research, development and design processes such as the use of Computational Fluid Dynamics (CFD) and prototype modelling tools for pharmaceutical equipment design.
Our Enzyme Indicators can supplement the concept data with real-time quantifiable evidence of the bio-decontamination efficacy. Biological Indicator failures during validation cycles can cause delays in the delivery of critical projects.
Our Enzyme Indicator technology “challenge area” design-specific reports can be analysed against the equipment design specification during handover testing and shared with your customers to inform future design modifications.
Preventing decontamination failure and product loss
Protak’s Athena® software is used to deliver quantifiable results in just 60 seconds per Enzyme Indicator. For OEMs, this reduces costs and time spent while boosting efficiency. Moreover, our Indicators have a long and stable shelf life, drastically reducing downtime.
Our PR2A luminometer provides data with substantially more information about what factors could impact the bio-decontamination process than conventional methods. As such, the implementation of Enzyme Indicators in validation can support decision-makers to act quickly.
Because our technology evaluates performance continuously, users can benefit from identifying any decline before it becomes critical. Enzyme Indicators proactively detect the risk of decontamination failure, meaning they can act as an early warning system to ensure confidence.
To find out more about Enzyme Indicator Technology, arrange a presentation from one of our technicians or simply ask a question, contact us today.